Cover
Cover - shares | 1 Months Ended | |
Sep. 30, 2021 | Nov. 06, 2021 | |
Cover [Abstract] | ||
Entity Registrant Name | BK TECHNOLOGIES CORPORATION | |
Entity Central Index Key | 0000002186 | |
Document Type | 10-Q | |
Amendment Flag | false | |
Current Fiscal Year End Date | --12-31 | |
Entity Small Business | true | |
Entity Shell Company | false | |
Entity Emerging Growth Company | false | |
Entity Current Reporting Status | Yes | |
Document Period End Date | Sep. 30, 2021 | |
Entity Filer Category | Non-accelerated Filer | |
Document Fiscal Period Focus | Q3 | |
Document Fiscal Year Focus | 2021 | |
Entity Common Stock Shares Outstanding | 16,814,336 | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Entity Interactive Data Current | Yes | |
Entity File Number | 001-32644 | |
Entity Incorporation State Country Code | NV | |
Entity Tax Identification Number | 83-4064262 | |
Entity Address Address Line 1 | 7100 Technology Drive | |
Entity Address City Or Town | West Melbourne | |
Entity Address State Or Province | FL | |
Entity Address Postal Zip Code | 32904 | |
City Area Code | 321 | |
Local Phone Number | 984-1414 | |
Security 12b Title | Common Stock, par value $.60 per share | |
Trading Symbol | BKTI | |
Security Exchange Name | NYSEAMER |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) | Sep. 30, 2021 | Dec. 31, 2020 |
Current assets: | ||
Cash and cash equivalents | $ 14,087,000 | $ 6,826,000 |
Trade accounts receivable, net | 7,646,000 | 6,466,000 |
Inventories, net | 15,981,000 | 10,545,000 |
Prepaid expenses and other current assets | 1,941,000 | 1,878,000 |
Total current assets | 39,655,000 | 25,715,000 |
Property, plant and equipment, net | 4,454,000 | 3,566,000 |
Right-of-use (ROU) asset | 2,497,000 | 2,887,000 |
Investment in securities | 2,324,000 | 2,014,000 |
Deferred tax assets, net | 4,116,000 | 4,300,000 |
Other assets | 88,000 | 112,000 |
Total assets | 53,134,000 | 38,594,000 |
Current liabilities: | ||
Accounts payable | 7,520,000 | 5,119,000 |
Accrued compensation and related taxes | 1,522,000 | 1,635,000 |
Accrued warranty expense | 666,000 | 791,000 |
Accrued other expenses and other current liabilities | 836,000 | 307,000 |
Dividends payable | 336,000 | 250,000 |
Short-term lease liability | 437,000 | 525,000 |
Credit facility | 1,470,000 | 0 |
Notes payable-current portion | 264,000 | 82,000 |
Deferred revenue | 992,000 | 757,000 |
Total current liabilities | 14,043,000 | 9,466,000 |
Notes payable, net of current portion | 673,000 | 247,000 |
Long-term lease liability | 2,385,000 | 2,702,000 |
Deferred revenue | 2,789,000 | 2,551,000 |
Total liabilities | 19,890,000 | 14,966,000 |
Stockholders' equity: | ||
Preferred stock; $1.00 par value; 1,000,000 authorized shares; none issued or outstanding | 0 | 0 |
Common stock; $.60 par value; 20,000,000 authorized shares; 18,264,736 and 13,962,366 issued and 16,814,336 and 12,511,966 outstanding shares at September 30, 2021, and December 31, 2020, respectively | 10,958,000 | 8,377,000 |
Additional paid-in capital | 35,701,000 | 26,346,000 |
Accumulated deficit | (8,013,000) | (5,693,000) |
Treasury stock, at cost, 1,450,400 shares at September 30, 2021, and December 31, 2020, respectively | (5,402,000) | (5,402,000) |
Total stockholders' equity | 33,244,000 | 23,628,000 |
Total liabilities and stockholders' equity | $ 53,134,000 | $ 38,594,000 |
CONDENSED CONSOLIDATED BALANC_2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares | Sep. 30, 2021 | Dec. 31, 2020 |
CONDENSED CONSOLIDATED BALANCE SHEETS | ||
Preferred stock, par value | $ 1 | $ 1 |
Preferred stock, shares authorized | 1,000,000 | 1,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Common stock, par value | $ 0.60 | $ 0.60 |
Common stock, shares authorized | 20,000,000 | 20,000,000 |
Common stock, shares issued | 18,264,736 | 13,962,366 |
Common stock, shares outstanding | 16,814,336 | 12,511,966 |
Treasury stock | 1,450,400 | 1,450,400 |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) | ||||
Sales, net | $ 12,626,000 | $ 12,760,000 | $ 32,526,000 | $ 33,586,000 |
Expenses | ||||
Cost of products | 8,488,000 | 7,448,000 | 20,914,000 | 20,316,000 |
Selling, general and administrative | 4,508,000 | 4,158,000 | 13,034,000 | 13,265,000 |
Total expenses | 12,996,000 | 11,606,000 | 33,948,000 | 33,581,000 |
Operating (loss) income | (370,000) | 1,154,000 | (1,422,000) | 5,000 |
Other (expense) income: | ||||
Net interest (expense) income | (19,000) | (6,000) | (37,000) | (4,000) |
Loss on disposal of property, plant and equipment | (6,000) | 0 | (6,000) | 0 |
(Loss) gain on investment in securities | (2,157,000) | (291,000) | 310,000 | (797,000) |
Other expense | (14,000) | (65,000) | (59,000) | (144,000) |
Total other (expense) income | (2,196,000) | (362,000) | 208,000 | (945,000) |
(Loss) income before income taxes | (2,566,000) | 792,000 | (1,214,000) | (940,000) |
Income tax expense | 0 | (2,000) | (184,000) | (30,000) |
Net (loss) income | $ (2,566,000) | $ 790,000 | $ (1,398,000) | $ (970,000) |
Net (loss) income per share-basic: | $ (0.15) | $ 0.06 | $ (0.10) | $ (0.08) |
Net (loss) income per share-diluted: | $ (0.15) | $ 0.06 | $ (0.10) | $ (0.08) |
Weighted average shares outstanding-basic | 16,795,356 | 12,505,096 | 14,307,847 | 12,518,587 |
Weighted average shares outstanding-diluted | 16,795,356 | 12,517,493 | 14,307,847 | 12,518,587 |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) | 9 Months Ended | |
Sep. 30, 2021 | Sep. 30, 2020 | |
Operating activities | ||
Net loss | $ (1,398,000) | $ (970,000) |
Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | ||
Inventories allowances | 572,000 | 142,000 |
Deferred tax expense | 184,000 | 101,000 |
Depreciation and amortization | 1,033,000 | 1,005,000 |
Share-based compensation expense-stock options | 215,000 | 94,000 |
Share-based compensation expense-restricted stock units | 162,000 | 112,000 |
(Gain) loss on investment in securities | (310,000) | 797,000 |
Changes in operating assets and liabilities: | ||
Trade accounts receivable | (1,180,000) | (1,814,000) |
Inventories | (6,008,000) | 5,098,000 |
Prepaid expenses and other current assets | (63,000) | 278,000 |
Other assets | 24,000 | 75,000 |
ROU asset and lease liability | (15,000) | 222,000 |
Accounts payable | 2,401,000 | (2,182,000) |
Accrued compensation and related taxes | (113,000) | 157,000 |
Accrued warranty expense | (125,000) | (337,000) |
Deferred revenue | 473,000 | 566,000 |
Accrued other expenses and other current liabilities | 529,000 | 181,000 |
Net cash (used in) provided by operating activities | (3,619,000) | 3,525,000 |
Investing activities | ||
Purchases of property, plant, and equipment | (1,921,000) | (742,000) |
Net cash used in investing activities | (1,921,000) | (742,000) |
Financing activities | ||
Proceeds from common stock issuance, net of costs | 11,559,000 | 0 |
Cash dividends paid | (836,000) | (752,000) |
Repurchase of common stock | 0 | (269,000) |
Proceeds from the credit facility and notes payable | 3,543,000 | 2,196,000 |
Repayment of the credit facility and notes payable | (1,465,000) | (2,253,000) |
Net cash provided by (used in) financing activities | 12,801,000 | (1,078,000) |
Net change in cash and cash equivalents | 7,261,000 | 1,705,000 |
Cash and cash equivalents, beginning of period | 6,826,000 | 4,676,000 |
Cash and cash equivalents, end of period | 14,087,000 | 6,381,000 |
Supplemental disclosure | ||
Cash paid for interest | 37,000 | 18,000 |
Non-cash financing activity | ||
Common stock issued under restricted stock units | $ 184,000 | $ 128,000 |
Condensed Consolidated Financia
Condensed Consolidated Financial Statements | 9 Months Ended |
Sep. 30, 2020 | |
Condensed Consolidated Financial Statements | |
1. Condensed Consolidated Financial Statements | 1. Condensed Consolidated Financial Statements Basis of Presentation The condensed consolidated balance sheet as of September 30, 2021, the condensed consolidated statements of operations for the three and nine months ended September 30, 2021 and 2020, and the condensed consolidated statements of cash flows for the nine months ended September 30, 2021 and 2020, have been prepared by BK Technologies Corporation, and are unaudited. On March 28, 2019, BK Technologies, Inc., the predecessor of BK Technologies Corporation, implemented a holding company reorganization, which resulted in BK Technologies Corporation becoming the direct parent company of, and the successor issuer to, BK Technologies, Inc. For the purpose of this report, references to “we” or the “Company” or its management or business at any period prior to the holding company reorganization (March 28, 2019) refer to those of BK Technologies, Inc., as the predecessor company and its subsidiaries and thereafter to those of BK Technologies Corporation and its subsidiaries, except as otherwise specified or to the extent the context otherwise indicates. In the opinion of management, all adjustments, which include normal, recurring adjustments, necessary for a fair presentation, have been made. All intercompany transactions and balances have been eliminated in consolidation. The condensed consolidated balance sheet at December 31, 2020, has been derived from the Company’s audited consolidated financial statements at that date. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020, as filed with the Securities and Exchange Commission (“SEC”) on March 3, 2021. The results of operations for the three and nine months ended September 30, 2021, are not necessarily indicative of the operating results for a full year. Principles of Consolidation The accounts of the Company have been included in the accompanying consolidated financial statements. All significant intercompany balances and transactions have been eliminated in consolidation. The Company consolidates entities in which it has a controlling financial interest. The Company determines whether it has a controlling financial interest in an entity by first evaluating whether the entity is a variable interest entity (“VIE”) or a voting interest entity. VIEs are entities in which (i) the total equity investment at risk is not sufficient to enable the entity to finance its activities independently, or (ii) the at-risk equity holders do not have the normal characteristics of a controlling financial interest. A controlling financial interest in a VIE is present when an enterprise has one or more variable interests that have both (i) the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance, and (ii) the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. The enterprise with a controlling financial interest is the primary beneficiary and consolidates the VIE. Voting interest entities lack one or more of the characteristics of a VIE. The usual condition for a controlling financial interest is ownership of a majority voting interest for a corporation or a majority of kick-out or participating rights for a limited partnership. When the Company does not have a controlling financial interest in an entity but exerts significant influence over the entity’s operating and financial policies (generally defined as owning a voting or economic interest of between 20% to 50%), the Company’s investment is accounted for under the equity method of accounting. If the Company does not have a controlling financial interest in, or exert significant influence over, an entity, the Company accounts for its investment at fair value, if the fair value option was elected, or at cost. The Company has an investment in FG Financial Group, Inc. (formerly 1347 Property Insurance Holdings, Inc.), made through FGI 1347 Holdings, LP, a consolidated VIE. Fair Value of Financial Instruments The Company’s financial instruments consist of cash and cash equivalents, trade accounts receivable, investment in securities, accounts payable, accrued expenses, notes payable, credit facilities, and other liabilities. As of September 30, 2021, and December 31, 2020, the carrying amount of cash and cash equivalents, trade accounts receivable, accounts payable, accrued expenses, notes payable, and other liabilities approximated their respective fair value due to the short-term nature and maturity of these instruments. The Company uses observable market data assumptions (Level 1 inputs, as defined in accounting guidance) that it believes market participants would use in pricing investment in securities. Recently Adopted Accounting Pronouncements In August 2018, the FASB issued ASU 2018-13, “Disclosure Framework–Changes to the Disclosure Requirements for Fair Value Measurement,” which modifies the disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement, including the removal of certain disclosure requirements. The amendments in the ASU are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted upon issuance of the ASU. The Company adopted this guidance as of January 1, 2020, and the adoption did not have an impact on its consolidated financial statements. Recent Accounting Pronouncements The Company does not discuss recent pronouncements that are not anticipated to have a material impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures. Change in Accounting Principle As disclosed in Note 4, on July 1, 2021, the Company changed its accounting to burden the material at the time of purchase receipts. Prior to July 1, 2021, the Company applied the material burden at the time the inventory was issued to work in progress. This change resulted in a net increase of approximately $1,300 in inventory and a net decrease of $1,300 in accumulated deficit as of July 1, 2021. The accounting change did not have a material effect on the loss from operations, net loss, or earnings per share for the three and nine months ended September 30, 2021. |
Significant Events and Transact
Significant Events and Transactions | 9 Months Ended |
Sep. 30, 2020 | |
Significant Events and Transactions | |
2. Significant Events and Transactions | 2. Significant Events and Transactions Pursuant to the Company’s capital return program, the Company’s Board of Directors declared a quarterly dividend of $0.02 per share of the Company’s common stock on September 23, 2021, to stockholders of record as of October 7, 2021. These dividends were paid on October 18, 2021. |
Allowance for Doubtful Accounts
Allowance for Doubtful Accounts | 9 Months Ended |
Sep. 30, 2020 | |
Allowance for Doubtful Accounts | |
3. Allowance for Doubtful Accounts | 3. Allowance for Doubtful Accounts The allowance for doubtful accounts on trade receivables was approximately $50 on gross trade receivables of $7,696 and $6,516 at September 30, 2021, and December 31, 2020, respectively. This allowance is used to state trade receivables at a net realizable value or the amount that the Company estimates will be collected of the Company’s gross trade receivables. |
Inventories, net
Inventories, net | 9 Months Ended |
Sep. 30, 2020 | |
Inventories, net | |
4. Inventories, net | 4. Inventories, Net On July 1, 2021, the Company changed its accounting to burden the material at the time of purchase receipts. Prior to July 1, 2021, the Company applied the material burden at the time the inventory was issued to work in progress. The Company believes that this method improves financial reporting by better reflecting the current value of inventory on the consolidated balance sheets, by providing better matching of revenues and expenses. The fiscal 2020 financial statements have been retrospectively adjusted to apply the new inventory change. The cumulative effect of this change on periods prior to those presented herein resulted in a net decrease in accumulated deficit of approximately $1,158 as of January 1, 2020. Inventories, which are presented net of allowance for obsolete and slow-moving inventory, consisted of the following: September 30, 2021 December 31, 2020 (as adjusted) Finished goods $ 2,565 $ 2,206 Work in process 4,342 3,672 Raw materials 9,074 4,667 $ 15,981 $ 10,545 Allowances for slow-moving, excess, or obsolete inventory are used to state the Company’s inventories at the lower of cost or net realizable value. The allowances were approximately $1,160 at September 30, 2021, compared with approximately $588 (as adjusted) at December 31, 2020. As a result of the retrospective application of this change in accounting method, the following financial statement line items within the accompanying fiscal 2020 Condensed Consolidated financial statements were adjusted as follows: As Originally Reported ($) Effect of Change ($) As Reported under Change in Accounting Principle ($) Consolidated Balance Sheets Assets Inventories, net as of December 31, 2020 9,441 1,104 10,545 Liabilities & Shareholders’ Equity Accumulated deficit as of December 31, 2020 (6,797 ) 1,104 (5,693 ) Consolidated Income Statements Cost of goods sold: Three months ended September 30, 2020 7,560 (112 ) 7,448 Nine months ended September 30, 2020 20,163 153 20,316 Income (loss) before income taxes: Three months ended September 30, 2020 680 112 792 Nine months ended September 30, 2020 (787 ) (153 ) (940 ) Net income (loss): Three months ended September 30, 2020 678 112 790 Nine months ended September 30, 2020 (817 ) (153 ) (970 ) Net (loss) income per share-basic and diluted: Three months ended September 30, 2020 0.05 0.01 0.06 Nine months ended September 30, 2020 (0.07 ) (0.01 ) (0.08 ) Consolidated Statements of Cash Flows Net loss as of September 30, 2020 (817 ) (153 ) (970 ) Inventories allowance 117 25 142 Inventories 4,970 128 5,098 |
Income Taxes
Income Taxes | 9 Months Ended |
Sep. 30, 2020 | |
Income Taxes | |
5. Income Taxes | 5. Income Taxes The Company has recorded income tax expense of $0 and $184 for the three and nine months ended September 30, 2021, respectively, compared with an income tax expense of $2 and $30 for the same periods last year. The Company’s income tax provision is based on management’s estimate of the effective tax rate for the full year. The tax provision (benefit) in any period will be affected by, among other things, permanent, as well as temporary, differences in the deductibility of certain items, changes in the valuation allowance related to net deferred tax assets, in addition to changes in tax legislation. As a result, the Company may experience significant fluctuations in the effective book tax rate (that is, tax expense divided by pre-tax book income) from period to period. As of September 30, 2021, the Company’s net deferred tax assets totaled approximately $4,116 and were primarily derived from research and development tax credits, deferred revenue, and net operating loss carryforwards. In order to fully utilize the net deferred tax assets, the Company will need to generate sufficient taxable income in future years. The Company analyzed all positive and negative evidence to determine if, based on the weight of available evidence, it is more likely than not to realize the benefit of the net deferred tax assets. The recognition of the net deferred tax assets and related tax benefits is based upon the Company’s conclusions regarding, among other considerations, estimates of future earnings based on information currently available and current and anticipated customers, contracts, and product introductions, as well as historical operating results and certain tax planning strategies. Based on the analysis of all available evidence, both positive and negative, the Company has concluded that it does not have the ability to generate sufficient taxable income in the necessary period to utilize the entire benefit for the deferred tax assets. Accordingly, the Company established a valuation allowance of $98. The Company cannot presently estimate what, if any, changes to the valuation of its deferred tax assets may be deemed appropriate in the future. If the Company incurs future losses, it may be necessary to record additional valuation allowance related to the deferred tax assets recognized as of September 30, 2021. |
Investment in Securities
Investment in Securities | 9 Months Ended |
Sep. 30, 2020 | |
Investment in Securities | |
6. Investment in Securities | 6. Investment in Securities 1347 LP The Company has an investment in a limited partnership, FGI 1347 Holdings, LP, of which the Company is the sole limited partner. FGI 1347 Holdings, LP (“1347 LP”), was established for the purpose of investing in securities. Affiliates of Fundamental Global GP, LLC (“FG”), serve as the general partner and the investment manager of 1347 LP, and the Company is the sole limited partner. As the sole limited partner, the Company is entitled to 100% of net assets held by 1347 LP. The general partner of 1347 LP is entitled to reimbursement of certain costs, fees, and expenses arising in connection with 1347 LP’s operations, as provided by the partnership agreement, upon approval by the Company’s Board of Directors. FG Financial Group As of September 30, 2021, the Company indirectly held approximately $63 in cash and 477,282 shares of FG Financial Group, Inc. (formerly 1347 Property Insurance Holdings, Inc.) (Nasdaq: FGF) (“FGF”), with fair value of $2,324, through an investment in 1347 LP. These shares were purchased in March and May 2018 for approximately $3,741. For the three and nine months ended September 30, 2021, the Company recognized unrealized loss of $2,157 and unrealized gains of $310, respectively, on the investment, compared with unrealized losses of $291 and $797, respectively for the same periods last year. There have been no costs, fees, and expenses paid to the general partner or its affiliates for any periods, including the three and nine months ended September 30, 2021 and 2020. As of September 30, 2021, the Company and the affiliates of FG, including, without limitation, Ballantyne Strong, Inc., beneficially owned in the aggregate 3,032,765 shares of FGF’s common stock, representing approximately 60.0% of FGF’s outstanding shares. Additionally, FG and its affiliates constitute the largest stockholder of the Company. Mr. Kyle Cerminara, a member of the Company’s Board of Directors, is Chief Executive Officer, Co-Founder and Partner of FG and serves as Chairman of the Board of Directors of Ballantyne Strong, Inc. Mr. Cerminara also serves as Chairman of the Board of Directors of FGF. |
Stockholders' Equity
Stockholders' Equity | 9 Months Ended |
Sep. 30, 2020 | |
Stockholders' equity: | |
7. Stockholders' Equity | 7. Stockholders’ Equity The changes in condensed consolidated stockholders’ equity for the three and nine months ended September 30, 2021 and 2020 *, are as follows: Common Stock Shares Common Stock Amount Additional Paid-In Capital Accumulated Deficit Treasury Stock Total Balance at December 31, 2020* 13,962,366 $ 8,377 $ 26,346 $ (5,693 ) $ (5,402 ) $ 23,628 Common stock issued under restricted stock units 24,505 15 (15 ) — — — Share-based compensation expense-stock options — — 32 — — 32 Share-based compensation expense-restricted stock units — — 103 — — 103 Common stock dividends ($0.02 per share) — — — (251 ) — (251 ) Net loss* — — — (670 ) — (670 ) Balance at March 31, 2021* 13,986,871 8,392 26,466 (6,614 ) (5,402 ) 22,842 Common stock issued, net of issuance costs 4,249,250 2,549 9,010 — — 11,559 Share-based compensation expense-stock options — — 33 — — 33 Share-based compensation expense-restricted stock units — — 25 — — 25 Net income* — — — 1,838 — 1,838 Balance at June 30, 2021* 18,236,121 10,941 35,534 (4,776 ) (5,402 ) 36,297 Common stock issued under restricted stock units 28,615 17 (17 ) — — — Share-based compensation expense-stock options — — 150 — — 150 Share-based compensation expense-restricted stock units — — 34 — — 34 Common stock dividends ($0.02 per share) — — — (671 ) — (671 ) Net loss — — — (2,566 ) — (2,566 ) Balance at September 30, 2021 18,264,736 $ 10,958 $ 35,071 $ (8,013 ) $ (5,402 ) $ 33,244 * The balances as of December 31, 2020, March 31, 2021, and June 30, 2021, and the amounts for the three months ended March 31, 2021, and June 30, 2021, have been adjusted to reflect the change in inventory accounting method as described in Notes 1 and 4 of the Condensed Consolidated Financial Statements Common Stock Shares Common Stock Amount Additional Paid-In Capital Accumulated Deficit Treasury Stock Total Balance at December 31, 2019 13,929,381 $ 8,357 $ 26,095 $ (6,043 ) $ (5,133 ) $ 23,276 Change in inventory accounting method — — — 1,158 — 1,158 Balance as of January 1, 2020 * 13,929,381 8,357 26,095 (4,885 ) — 24,434 Share-based compensation expense-stock options — — 30 — — 30 Share-based compensation expense-restricted stock units — — 21 — — 21 Common stock dividends ($0.02 per share) — — — (250 ) — (250 ) Net loss * — — — (1,466 ) — (1,466 ) Repurchase of common stock — — — — (243 ) (243 ) Balance at March 31, 2020 * 13,929,381 8,357 26,146 (6,601 ) (5,376 ) 22,526 Common stock issued under restricted stock units 14,439 9 (9 ) — — — Share-based compensation expense-stock options — — 30 — — 30 Share-based compensation expense-restricted stock units — — 68 — — 68 Common stock dividends ($0.02 per share) — — — (252 ) — (252 ) Net loss * — — — (294 ) — (294 ) Repurchase of common stock — — — — (26 ) (26 ) Balance at June 30, 2020 * 13,943,820 8.366 26,235 (7,147 ) (5,402 ) 22,052 Common stock issued under restricted stock units 18,546 11 (11 ) — — — Share-based compensation expense-stock options — — 34 — — 34 Share-based compensation expense-restricted stock units — — 23 — — 23 Common stock dividends ($0.02 per share) — — — (250 ) — (250 ) Net income * — — — 790 — 790 Balance at September 30, 2020 * 13,962,366 $ 8,377 $ 26,281 $ (6,607 ) $ (5,402 ) $ 22,649 * The balances as of January 1, 2020, March 31, 2020, June 30, 2020, and September 30, 2020, and the amounts for the three months ended March 31, 2020, June 30, 2020, and September 30, 2020, have been adjusted to reflect the change in inventory accounting method as described in Notes 1 and 4 of the Condensed Consolidated Financial Statements. |
Income (Loss) Per Share
Income (Loss) Per Share | 9 Months Ended |
Sep. 30, 2020 | |
Income (Loss) Per Share | |
8. Loss per Share | 8. Income (Loss) Per Share The following table sets forth the computation of basic and diluted loss per share: Three Months Ended Nine Months Ended September 30, 2021 September 30, 2020 * September 30, 2021 September 30, 2020 * Numerator: Net (loss) income for basic and diluted earnings per share $ (2,566 ) $ 790 $ (1,398 ) $ (970 ) Denominator for basic loss per share weighted average shares 16,795,356 12,505,096 14,307,847 12,518,587 Effect of dilutive securities: Options and restricted stock units — 12,397 — — Denominator for diluted loss per share weighted average shares 16,795,356 12,517,493 14,307,847 12,518,587 Basic income (loss) per share $ (0.15 ) $ 0.06 $ (0.10 ) $ (0.08 ) Diluted income (loss) per share $ (0.15 ) $ 0.06 $ (0.10 ) $ (0.08 ) Approximately 681,500 stock options and 171,316 restricted stock units for the three and nine months ended September 30, 2021, respectively, and 480,900 and 505,900 stock options and 0 and 147,038 restricted stock units for the three and nine months ended September 30, 2020, respectively, were excluded from the calculation because they were anti-dilutive. * The amounts for 2020 and the amounts prior to July 1, 2021, have been adjusted to reflect the change in inventory accounting method, as described in Notes 1and 4 to Condensed Consolidated Financial Statements. |
Non-Cash Share-Based Employee C
Non-Cash Share-Based Employee Compensation | 9 Months Ended |
Sep. 30, 2020 | |
Non-Cash Share-Based Employee Compensation | |
9. Non-Cash Share-Based Employee Compensation | 9. Non-Cash Share-Based Employee Compensation The Company has an employee and non-employee director share-based incentive compensation plan. Related to these programs, the Company recorded non-cash share-based employee compensation expense of $150 and $215 for the three and nine months ended September 30, 2021, respectively, compared with $34 and $94, respectively, for the same period last year. The Company considers its non-cash share-based employee compensation expenses as a component of cost of products and selling, general and administrative expenses. There was no non-cash share-based employee compensation expense capitalized as part of capital expenditures or inventory for the periods presented. The Company uses the Black-Scholes-Merton option valuation model to calculate the fair value of stock option grants under this plan. The non-cash share-based employee compensation expense recorded in the three and nine months ended September 30, 2021, was calculated using certain assumptions. Such assumptions are described more comprehensively in Note 10 (Share-Based Employee Compensation) of the Notes to the Company’s consolidated financial statements included in its Annual Report on Form 10-K for the fiscal year ended December 31, 2020. A summary of activity under the Company’s stock option plans during the nine months ended September 30, 2021, is presented below: As of January 1, 2021 Stock Options Wgt. Avg. Exercise Price ($) Per Share Wgt. Avg. Remaining Contractual Life (Years) Wgt. Avg. Grant Date Fair Value ($) Per Share Aggregate Intrinsic Value ($) Outstanding 489,000 3.96 7.23 1.51 20,000 Vested 185,800 4.15 5.65 1.55 20,000 Nonvested 303,200 3.84 8.20 1.49 — Period activity Issued 202,500 3.08 — 1.16 — Exercised — — — — — Forfeited — — — — — Expired 10,000 4.55 — 1.06 — As of September 30, 2021 Outstanding 681,500 3.69 7.57 1.41 15,000 Vested 359,600 3.82 6.88 1.44 15,000 Nonvested 321,900 3.54 8.34 1.38 — Restricted Stock Units On July 30, 2021, the Company granted to each non-employee director restricted stock units with a grant-date fair value of $50 per award (resulting in total aggregate grant-date fair value of $250), which will vest in five equal, annual installments beginning with the first anniversary of the grant date, subject to the director’s continued service through such date, provided that, if the director makes himself available and consents to be nominated by the Company for continued service as a director, but is not nominated for the Board for election by stockholders, other than for good reason, as determined by the Board in its discretion, then the restricted stock units shall vest in full as of the director’s last date of service as a director of the Company. On March 4, 2021, upon the resignation of former director Lewis Johnson, the Company, at the direction of the Board of Directors, accelerated the vesting of Mr. Johnson’s unvested restricted stock units granted September 6, 2018, September 6, 2019, and August 24, 2020, and issued 24,505 shares of common stock to Mr. Johnson. On August 24, 2020, the Company granted to each non-employee director restricted stock units with a grant-date fair value of $40 per award (resulting in total aggregate grant-date fair value of $240), which will vest in five equal, annual installments beginning with the first anniversary of the grant date, subject to the director’s continued service through such date, provided that, if the director makes himself available and consents to be nominated by the Company for continued service as a director, but is not nominated for the Board for election by stockholders, other than for good reason, as determined by the Board in its discretion, then the restricted stock units shall vest in full as of the director’s last date of service as a director of the Company. On April 24, 2020, upon the resignation of former director Ryan Turner, the Company, at the direction of the Board of Directors, accelerated the vesting of Mr. Turner’s unvested restricted stock units granted September 6, 2019, and September 6, 2018, and issued 10,389 and 4,050 shares of common stock, respectively. On September 6, 2019, the Company granted to each non-employee director restricted stock units with a grant-date fair value of $40 per award (resulting in total aggregate grant-date fair value of $280), which will vest in five equal, annual installments beginning with the first anniversary of the grant date, subject to the director’s continued service through such date, provided that, if the director makes himself available and consents to be nominated by the Company for continued service as a director, but is not nominated for the Board for election by stockholders, other than for good reason, as determined by the Board in its discretion, then the restricted stock units shall vest in full as of the director’s last date of service as a director of the Company. On September 6, 2018, the Company granted to each non-employee director restricted stock units with a grant-date fair value of $20 per award (resulting in total aggregate grant-date fair value of $140), which vest in five equal, annual installments beginning with the first anniversary of the grant date, subject to the director’s continued service through such date, provided that, if the director makes himself available and consents to be nominated by the Company for continued service as a director, but is not nominated for the Board for election by stockholders, other than for good reason, as determined by the Board in its discretion, then the restricted stock units vest in full as of the director’s last date of service as a director of the Company. On June 4, 2018, the Company granted to each non-employee director restricted stock units with a grant fair value of $20 per award (resulting in total aggregate grant-date fair value of $140), which vested on June 4, 2019. There were 171,316 and 147,038 restricted stock units outstanding as of September 30, 2021, and December 31, 2020, respectively. The Company recorded non-cash restricted stock unit compensation expense of $34 and $162 for the three and nine months ended September 30, 2021, respectively, compared with $23 and $112, respectively for the same period last year. |
Commitments and Contingencies
Commitments and Contingencies | 9 Months Ended |
Sep. 30, 2020 | |
Commitments and Contingencies | |
10. Commitments and Contingencies | 10. Commitments and Contingencies From time to time, the Company may be involved in various claims and legal actions arising in the ordinary course of its business. On a quarterly basis, the Company assesses its liabilities and contingencies in connection with outstanding legal proceedings utilizing the latest information available. Where it is probable that the Company will incur a loss and the amount of the loss can be reasonably estimated, it records a liability in its consolidated financial statements. These legal accruals may be increased or decreased to reflect any relevant developments on a quarterly basis. Where a loss is not probable or the amount of the loss is not estimable, the Company does not accrue legal reserves, consistent with applicable accounting guidance. There were no pending material claims or legal matters as of September 30, 2021. In December 2019, a novel strain of the coronavirus (COVID-19) surfaced in Wuhan, China, which spread globally and was declared a pandemic by the World Health Organization in March 2020. The pandemic may have the potential of adversely impacting our business and financial performance in the future. The extent of the potential impact will depend on future developments, which are uncertain and, given the continuing evolution of the COVID-19 pandemic and the global responses to curb its spread, cannot be predicted. In addition, the pandemic has significantly increased economic uncertainty. Even after the COVID-19 pandemic has subsided, we may continue to experience an adverse impact to our business as a result of its national and, to some extent, global economic impact, including any recession that may occur in the future. Purchase Commitments As of September 30, 2021, the Company had purchase commitments for inventory totaling approximately $13,142. Significant Customers Sales to United States government agencies represented approximately $6,371 (50.5%) and $13,237 (39.4%) of the Company’s net total sales for the three and nine months ended September 30, 2021, respectively, compared with approximately $8,476 (66.4%) and $19,321 (57.5%), respectively, for the same period last year. Accounts receivable from agencies of the United States government were $5,197 as of September 30, 2021, compared with approximately $3,261 at the same date last year. |
Debt
Debt | 9 Months Ended |
Sep. 30, 2020 | |
Debt | |
11. Debt | 11. Debt BK Technologies, Inc. (“BK Inc.”), a wholly owned subsidiary of the Company, entered into a $5,000 Credit Agreement and a related Line of Credit Note (the “Note” and collectively with the Credit Agreement, the “Credit Agreement”) with JPMorgan Chase Bank, N.A. (“JPMC”) on January 30, 2020. The Credit Agreement provides for a revolving line of credit of up to $5,000, with availability under the line of credit subject to a borrowing base calculated as a percentage of accounts receivable and inventory. Proceeds of borrowings under the Credit Agreement may be used for general corporate purposes. The line of credit is collateralized by a blanket lien on all personal property of BK Technologies, Inc., pursuant to the terms of the Continuing Security Agreement with JPMC. The Company and each subsidiary of BK Inc. are guarantors of BK Technologies, Inc.’s obligations under the Credit Agreement, in accordance with the terms of the Continuing Guaranty. On January 26, 2021, the Company extended this revolving credit facility for one year, through January 31, 2022. Borrowings under the Credit Agreement will bear interest at a rate per annum equal to one-month LIBOR or zero if the LIBOR is less than zero) plus a margin of 1.90% (1.973% as of September 30, 2021). The line of credit, as modified, is to be repaid in monthly payments of interest only, payable in arrears, commencing on February 1, 2020, with all outstanding principal and interest to be payable in full at maturity (January 31, 2022). The Credit Agreement contains certain customary restrictive covenants, including restrictions on liens, indebtedness, loans and guarantees, acquisitions and mergers, sales of assets, and stock repurchases by BK Technologies, Inc. The Credit Agreement contains one financial covenant requiring BK Technologies, Inc., to maintain a tangible net worth of at least $20,000 at any fiscal quarter end. The Credit Agreement provides for customary events of default, including: (1) failure to pay principal, interest or fees under the Credit Agreement when due and payable; (2) failure to comply with other covenants and agreements contained in the Credit Agreement and the other documents executed in connection therewith; (3) the making of false or inaccurate representations and warranties; (4) defaults under other agreements with JPMC or under other debt or other obligations of BK Technologies, Inc.; (5) money judgments and material adverse changes; (6) a change in control or ceasing to operate business in the ordinary course; and (7) certain events of bankruptcy or insolvency. Upon the occurrence of an event of default, JPMC may declare the entire unpaid balance immediately due and payable and/or exercise any and all remedial and other rights under the Credit Agreement. BK Technologies, Inc. was in compliance with all covenants under the Credit Agreement as of September 30, 2021, and the date of filing this report. As of September 30, 2021, and the date of filing this report, the Company had an outstanding balance of $1,470, and a net balance availability of $3,530 under the Credit Agreement. On April 6, 2021, BK Technologies, Inc., a wholly owned subsidiary of BK Technologies Corporation, and JPMC, as a lender, entered into a Master Loan Agreement in the amount of $743 to finance various items of manufacturing equipment. The loan is collateralized by the equipment purchased using the proceeds. The Master Loan Agreement is payable in 48 equal monthly principal and interest payments of approximately $16 beginning on May 8, 2021, matures on April 8, 2025, and bears a fixed interest rate of 3.0%. On September 25, 2019, BK Technologies, Inc., a wholly owned subsidiary of the Company, and U.S. Bank Equipment Finance, a division of U.S. Bank National Association, as a lender, entered into a Master Loan Agreement in the amount of $425 to finance various items of manufacturing equipment. The loan is collateralized by the equipment purchased using the proceeds. The Master Loan Agreement is payable in 60 equal monthly principal and interest payments of approximately $8 beginning on October 25, 2019, matures on September 25, 2024, and bears a fixed interest rate of 5.11%. Current balances of note payable at September 30, 2021, and December 30, 2020, are set forth in the table below: September 30, 2021 December 31, 2020 Note payable-US. Bank $ 84 $ 82 Note payable-JP Morgan Chase Bank 180 — $ 264 $ 82 Long-term balances of note payable at September 30, 2021, and December 30, 2020, are set forth in the table below: September 30, 2021 December 31, 2020 Note payable-US. Bank $ 183 $ 247 Note payable-JP Morgan Chase Bank 490 — $ 673 $ 247 |
Leases
Leases | 9 Months Ended |
Sep. 30, 2020 | |
Leases | |
12. Leases | 12. Leases The Company accounts for its leasing arrangements in accordance with Topic 842, “Leases”. The Company leases manufacturing and office facilities and equipment under operating leases and determines if an arrangement is a lease at inception. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of its leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The Company has lease agreements with lease and non-lease components, which are accounted for separately. The Company leases approximately 54,000 square feet (not in thousands) of industrial space in West Melbourne, Florida, under a non-cancellable operating lease. The lease has the expiration date of September 30, 2027. Annual rental, maintenance and tax expenses for the facility are approximately $491. In February 2020, the Company entered into a lease for 6,857 square feet (not in thousands) of office space at Sawgrass Technology Park, 1619 NW 136th Avenue in Sunrise, Florida, for a period of 64 months commencing July 1, 2020. Annual rental, maintenance and tax expenses for the facility will be approximately $196 for the first year, increasing by approximately 3% for each subsequent 12-month period. In March 2021, the Company executed an agreement for the termination of its lease for 8,100 square feet (not in thousands) of office space in Lawrence, Kansas, effective March 31, 2021, and recognized a termination lease expense of approximately $53. The original term of the lease was through December 31, 2021. Lease costs consisted of the following: Three Months Ended Nine Months Ended September 30, 2021 September 30, 2020 September 30, 2021 September 30, 2020 Operating lease cost $ 136 $ 158 $ 438 $ 445 Short-term lease cost — — — 2 Variable lease cost 33 33 98 96 Total lease cost $ 169 $ 191 $ 536 $ 543 Supplemental cash flow information related to leases was as follows: Three Months Ended Nine months Ended September 30, 2021 September 30, 2020 September 30, 2021 September 30, 2020 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows (fixed payments) $ 143 $ 141 $ 495 $ 384 Operating cash flows (liability reduction) $ 104 $ 102 $ 375 $ 267 ROU assets obtained in exchange for lease obligations: Operating leases $ — $ 419 $ 14 $ 454 Other information related to operating leases was as follows: September 30, 2021 Weighted average remaining lease term (in years) 5.44 Weighted average discount rate 5.50 % Maturity of lease liabilities as of September 30, 2021, were as follows: September 30, 2021 Remaining three months of 2021 $ 144 2022 582 2023 595 2024 608 2025 618 Thereafter 722 Total payments 3,269 Less: imputed interest (447 ) Total liability $ 2,822 |
Condensed Consolidated Financ_2
Condensed Consolidated Financial Statements (Policies) | 1 Months Ended |
Sep. 30, 2021 | |
Condensed Consolidated Financial Statements (Policies) | |
Basis of Presentation | The condensed consolidated balance sheet as of September 30, 2021, the condensed consolidated statements of operations for the three and nine months ended September 30, 2021 and 2020, and the condensed consolidated statements of cash flows for the nine months ended September 30, 2021 and 2020, have been prepared by BK Technologies Corporation, and are unaudited. On March 28, 2019, BK Technologies, Inc., the predecessor of BK Technologies Corporation, implemented a holding company reorganization, which resulted in BK Technologies Corporation becoming the direct parent company of, and the successor issuer to, BK Technologies, Inc. For the purpose of this report, references to “we” or the “Company” or its management or business at any period prior to the holding company reorganization (March 28, 2019) refer to those of BK Technologies, Inc., as the predecessor company and its subsidiaries and thereafter to those of BK Technologies Corporation and its subsidiaries, except as otherwise specified or to the extent the context otherwise indicates. In the opinion of management, all adjustments, which include normal, recurring adjustments, necessary for a fair presentation, have been made. All intercompany transactions and balances have been eliminated in consolidation. The condensed consolidated balance sheet at December 31, 2020, has been derived from the Company’s audited consolidated financial statements at that date. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020, as filed with the Securities and Exchange Commission (“SEC”) on March 3, 2021. The results of operations for the three and nine months ended September 30, 2021, are not necessarily indicative of the operating results for a full year. |
Principles of Consolidation | The accounts of the Company have been included in the accompanying consolidated financial statements. All significant intercompany balances and transactions have been eliminated in consolidation. The Company consolidates entities in which it has a controlling financial interest. The Company determines whether it has a controlling financial interest in an entity by first evaluating whether the entity is a variable interest entity (“VIE”) or a voting interest entity. VIEs are entities in which (i) the total equity investment at risk is not sufficient to enable the entity to finance its activities independently, or (ii) the at-risk equity holders do not have the normal characteristics of a controlling financial interest. A controlling financial interest in a VIE is present when an enterprise has one or more variable interests that have both (i) the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance, and (ii) the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. The enterprise with a controlling financial interest is the primary beneficiary and consolidates the VIE. Voting interest entities lack one or more of the characteristics of a VIE. The usual condition for a controlling financial interest is ownership of a majority voting interest for a corporation or a majority of kick-out or participating rights for a limited partnership. When the Company does not have a controlling financial interest in an entity but exerts significant influence over the entity’s operating and financial policies (generally defined as owning a voting or economic interest of between 20% to 50%), the Company’s investment is accounted for under the equity method of accounting. If the Company does not have a controlling financial interest in, or exert significant influence over, an entity, the Company accounts for its investment at fair value, if the fair value option was elected, or at cost. The Company has an investment in FG Financial Group, Inc. (formerly 1347 Property Insurance Holdings, Inc.), made through FGI 1347 Holdings, LP, a consolidated VIE. |
Fair Value | The Company’s financial instruments consist of cash and cash equivalents, trade accounts receivable, investment in securities, accounts payable, accrued expenses, notes payable, credit facilities, and other liabilities. As of September 30, 2021, and December 31, 2020, the carrying amount of cash and cash equivalents, trade accounts receivable, accounts payable, accrued expenses, notes payable, and other liabilities approximated their respective fair value due to the short-term nature and maturity of these instruments. The Company uses observable market data assumptions (Level 1 inputs, as defined in accounting guidance) that it believes market participants would use in pricing investment in securities. |
Recently Adopted Accounting Pronouncements | In August 2018, the FASB issued ASU 2018-13, “Disclosure Framework–Changes to the Disclosure Requirements for Fair Value Measurement,” which modifies the disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement, including the removal of certain disclosure requirements. The amendments in the ASU are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted upon issuance of the ASU. The Company adopted this guidance as of January 1, 2020, and the adoption did not have an impact on its consolidated financial statements. |
Recent Accounting Pronouncements | The Company does not discuss recent pronouncements that are not anticipated to have a material impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures. |
Change in Accounting Principle | As disclosed in Note 4, on July 1, 2021, the Company changed its accounting to burden the material at the time of purchase receipts. Prior to July 1, 2021, the Company applied the material burden at the time the inventory was issued to work in progress. This change resulted in a net increase of approximately $1,300 in inventory and a net decrease of $1,300 in accumulated deficit as of July 1, 2021. The accounting change did not have a material effect on the loss from operations, net loss, or earnings per share for the three and nine months ended September 30, 2021. |
Inventories, net (Tables)
Inventories, net (Tables) | 1 Months Ended |
Sep. 30, 2021 | |
Inventories, net | |
Components of inventory | September 30, 2021 December 31, 2020 (as adjusted) Finished goods $ 2,565 $ 2,206 Work in process 4,342 3,672 Raw materials 9,074 4,667 $ 15,981 $ 10,545 |
Schedule of condensed consolidated financial statements | As Originally Reported ($) Effect of Change ($) As Reported under Change in Accounting Principle ($) Consolidated Balance Sheets Assets Inventories, net as of December 31, 2020 9,441 1,104 10,545 Liabilities & Shareholders’ Equity Accumulated deficit as of December 31, 2020 (6,797 ) 1,104 (5,693 ) Consolidated Income Statements Cost of goods sold: Three months ended September 30, 2020 7,560 (112 ) 7,448 Nine months ended September 30, 2020 20,163 153 20,316 Income (loss) before income taxes: Three months ended September 30, 2020 680 112 792 Nine months ended September 30, 2020 (787 ) (153 ) (940 ) Net income (loss): Three months ended September 30, 2020 678 112 790 Nine months ended September 30, 2020 (817 ) (153 ) (970 ) Net (loss) income per share-basic and diluted: Three months ended September 30, 2020 0.05 0.01 0.06 Nine months ended September 30, 2020 (0.07 ) (0.01 ) (0.08 ) Consolidated Statements of Cash Flows Net loss as of September 30, 2020 (817 ) (153 ) (970 ) Inventories allowance 117 25 142 Inventories 4,970 128 5,098 |
Stockholders' Equity (Tables)
Stockholders' Equity (Tables) | 1 Months Ended |
Sep. 30, 2021 | |
Stockholders' Equity (Tables) | |
Changes in consolidated stockholders' equity | Common Stock Shares Common Stock Amount Additional Paid-In Capital Accumulated Deficit Treasury Stock Total Balance at December 31, 2020* 13,962,366 $ 8,377 $ 26,346 $ (5,693 ) $ (5,402 ) $ 23,628 Common stock issued under restricted stock units 24,505 15 (15 ) — — — Share-based compensation expense-stock options — — 32 — — 32 Share-based compensation expense-restricted stock units — — 103 — — 103 Common stock dividends ($0.02 per share) — — — (251 ) — (251 ) Net loss* — — — (670 ) — (670 ) Balance at March 31, 2021* 13,986,871 8,392 26,466 (6,614 ) (5,402 ) 22,842 Common stock issued, net of issuance costs 4,249,250 2,549 9,010 — — 11,559 Share-based compensation expense-stock options — — 33 — — 33 Share-based compensation expense-restricted stock units — — 25 — — 25 Net income* — — — 1,838 — 1,838 Balance at June 30, 2021* 18,236,121 10,941 35,534 (4,776 ) (5,402 ) 36,297 Common stock issued under restricted stock units 28,615 17 (17 ) — — — Share-based compensation expense-stock options — — 150 — — 150 Share-based compensation expense-restricted stock units — — 34 — — 34 Common stock dividends ($0.02 per share) — — — (671 ) — (671 ) Net loss — — — (2,566 ) — (2,566 ) Balance at September 30, 2021 18,264,736 $ 10,958 $ 35,071 $ (8,013 ) $ (5,402 ) $ 33,244 Common Stock Shares Common Stock Amount Additional Paid-In Capital Accumulated Deficit Treasury Stock Total Balance at December 31, 2019 13,929,381 $ 8,357 $ 26,095 $ (6,043 ) $ (5,133 ) $ 23,276 Change in inventory accounting method — — — 1,158 — 1,158 Balance as of January 1, 2020 * 13,929,381 8,357 26,095 (4,885 ) — 24,434 Share-based compensation expense-stock options — — 30 — — 30 Share-based compensation expense-restricted stock units — — 21 — — 21 Common stock dividends ($0.02 per share) — — — (250 ) — (250 ) Net loss * — — — (1,466 ) — (1,466 ) Repurchase of common stock — — — — (243 ) (243 ) Balance at March 31, 2020 * 13,929,381 8,357 26,146 (6,601 ) (5,376 ) 22,526 Common stock issued under restricted stock units 14,439 9 (9 ) — — — Share-based compensation expense-stock options — — 30 — — 30 Share-based compensation expense-restricted stock units — — 68 — — 68 Common stock dividends ($0.02 per share) — — — (252 ) — (252 ) Net loss * — — — (294 ) — (294 ) Repurchase of common stock — — — — (26 ) (26 ) Balance at June 30, 2020 * 13,943,820 8.366 26,235 (7,147 ) (5,402 ) 22,052 Common stock issued under restricted stock units 18,546 11 (11 ) — — — Share-based compensation expense-stock options — — 34 — — 34 Share-based compensation expense-restricted stock units — — 23 — — 23 Common stock dividends ($0.02 per share) — — — (250 ) — (250 ) Net income * — — — 790 — 790 Balance at September 30, 2020 * 13,962,366 $ 8,377 $ 26,281 $ (6,607 ) $ (5,402 ) $ 22,649 |
Income (Loss) Per Share (Tables
Income (Loss) Per Share (Tables) | 1 Months Ended |
Sep. 30, 2021 | |
Income (Loss) Per Share | |
Computation of basic and diluted loss per share | Three Months Ended Nine Months Ended September 30, 2021 September 30, 2020 * September 30, 2021 September 30, 2020 * Numerator: Net (loss) income for basic and diluted earnings per share $ (2,566 ) $ 790 $ (1,398 ) $ (970 ) Denominator for basic loss per share weighted average shares 16,795,356 12,505,096 14,307,847 12,518,587 Effect of dilutive securities: Options and restricted stock units — 12,397 — — Denominator for diluted loss per share weighted average shares 16,795,356 12,517,493 14,307,847 12,518,587 Basic income (loss) per share $ (0.15 ) $ 0.06 $ (0.10 ) $ (0.08 ) Diluted income (loss) per share $ (0.15 ) $ 0.06 $ (0.10 ) $ (0.08 ) |
Non-Cash Share-Based Employee_2
Non-Cash Share-Based Employee Compensation (Tables) | 1 Months Ended |
Sep. 30, 2021 | |
Non-Cash Share-Based Employee Compensation (Tables) | |
Summary of stock option activity | As of January 1, 2021 Stock Options Wgt. Avg. Exercise Price ($) Per Share Wgt. Avg. Remaining Contractual Life (Years) Wgt. Avg. Grant Date Fair Value ($) Per Share Aggregate Intrinsic Value ($) Outstanding 489,000 3.96 7.23 1.51 20,000 Vested 185,800 4.15 5.65 1.55 20,000 Nonvested 303,200 3.84 8.20 1.49 — Period activity Issued 202,500 3.08 — 1.16 — Exercised — — — — — Forfeited — — — — — Expired 10,000 4.55 — 1.06 — As of September 30, 2021 Outstanding 681,500 3.69 7.57 1.41 15,000 Vested 359,600 3.82 6.88 1.44 15,000 Nonvested 321,900 3.54 8.34 1.38 — |
Debt (Tables)
Debt (Tables) | 1 Months Ended |
Sep. 30, 2021 | |
Debt | |
Schedule of current balances of note payable | September 30, 2021 December 31, 2020 Note payable-US. Bank $ 84 $ 82 Note payable-JP Morgan Chase Bank 180 — $ 264 $ 82 |
Schedule of long-term balances of note payable | September 30, 2021 December 31, 2020 Note payable-US. Bank $ 183 $ 247 Note payable-JP Morgan Chase Bank 490 — $ 673 $ 247 |
Leases (Tables)
Leases (Tables) | 1 Months Ended |
Sep. 30, 2021 | |
Leases | |
Lease cost | Three Months Ended Nine Months Ended September 30, 2021 September 30, 2020 September 30, 2021 September 30, 2020 Operating lease cost $ 136 $ 158 $ 438 $ 445 Short-term lease cost — — — 2 Variable lease cost 33 33 98 96 Total lease cost $ 169 $ 191 $ 536 $ 543 |
Supplemental cash flow information related to leases | Three Months Ended Nine months Ended September 30, 2021 September 30, 2020 September 30, 2021 September 30, 2020 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows (fixed payments) $ 143 $ 141 $ 495 $ 384 Operating cash flows (liability reduction) $ 104 $ 102 $ 375 $ 267 ROU assets obtained in exchange for lease obligations: Operating leases $ — $ 419 $ 14 $ 454 |
Other information related to operating leases | September 30, 2021 Weighted average remaining lease term (in years) 5.44 Weighted average discount rate 5.50 % |
Maturity of lease liabilities | September 30, 2021 Remaining three months of 2021 $ 144 2022 582 2023 595 2024 608 2025 618 Thereafter 722 Total payments 3,269 Less: imputed interest (447 ) Total liability $ 2,822 |
Condensed Consolidated Financ_3
Condensed Consolidated Financial Statements (Details Narrative) | 9 Months Ended |
Sep. 30, 2021USD ($) | |
Net decrease in accumulated deficit | $ 1,158 |
July 1, 2021 [Member] | |
Net decrease in accumulated deficit | 1,300 |
Net decrease in inventory | $ 1,300 |
Minimum [Member] | |
Voting interest | 20.00% |
Maximum [Member] | |
Voting interest | 50.00% |
Significant Events and Transa_2
Significant Events and Transactions (Details Narrative) | Sep. 23, 2021$ / shares |
Board Of Directors [Member] | |
Price per share | $ 0.02 |
Allowance for Doubtful Accoun_2
Allowance for Doubtful Accounts (Details Narrative) - USD ($) $ in Thousands | Sep. 30, 2021 | Dec. 31, 2020 |
Allowance for Doubtful Accounts (Details Narrative) | ||
Allowance for doubtful accounts on trade receivables | $ 50 | |
Accounts receivable, gross | $ 7,696 | $ 6,516 |
Inventories, Net (Details)
Inventories, Net (Details) - USD ($) $ in Thousands | Sep. 30, 2021 | Dec. 31, 2020 |
Inventories, net | ||
Finished goods | $ 2,565 | $ 2,206 |
Work in process | 4,342 | 3,672 |
Raw materials | 9,074 | 4,667 |
Total inventory | $ 15,981 | $ 10,545 |
Inventories, Net (Details 1)
Inventories, Net (Details 1) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | Dec. 31, 2020 | |
Total inventory | $ 15,981 | $ 15,981 | $ 10,545 | ||
Accumulated deficit | (8,013) | (8,013) | (5,693) | ||
Consolidated Income Statements | |||||
Cost of goods sold: | 7,448 | 20,316 | |||
Income (loss) before income taxes | (2,566) | $ 792 | (1,214) | $ (940) | |
Net income (loss): | $ (2,566) | $ 790 | $ (1,398) | $ (970) | |
Net (loss) income per share-basic and diluted: | $ 0.06 | $ (0.08) | |||
Net loss | $ (970) | ||||
Inventories allowance | 142 | ||||
Inventories | 5,098 | ||||
As Originally Reported [Member] | |||||
Total inventory | 9,441 | ||||
Accumulated deficit | (6,797) | ||||
Consolidated Income Statements | |||||
Cost of goods sold: | $ 7,560 | 20,163 | |||
Income (loss) before income taxes | 680 | (787) | |||
Net income (loss): | $ 678 | $ (817) | |||
Net (loss) income per share-basic and diluted: | $ 0.05 | $ (0.07) | |||
Net loss | $ (817) | ||||
Inventories allowance | 117 | ||||
Inventories | 4,970 | ||||
Effect of Change [Member] | |||||
Total inventory | 1,104 | ||||
Accumulated deficit | $ 1,104 | ||||
Consolidated Income Statements | |||||
Cost of goods sold: | $ (112) | 153 | |||
Income (loss) before income taxes | (112) | 153 | |||
Net income (loss): | $ (112) | $ 153 | |||
Net (loss) income per share-basic and diluted: | $ 0.01 | $ (0.01) | |||
Net loss | $ (153) | ||||
Inventories allowance | 25 | ||||
Inventories | $ 128 |
Inventories, Net (Details Narra
Inventories, Net (Details Narrative) - USD ($) | 9 Months Ended | |
Sep. 30, 2021 | Dec. 31, 2020 | |
Inventories, net | ||
Reserves for slow-moving, excess, or obsolete inventory | $ 1,160,000 | $ 588,000 |
Net decrease in accumulated deficit | $ 1,158 |
Income (Loss) per Share (Detail
Income (Loss) per Share (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Numerator: | ||||
Net income (loss): | $ (2,566) | $ 790 | $ (1,398) | $ (970) |
Denominator: | ||||
Denominator for basic loss per share weighted average shares | 16,795,356 | 12,505,096 | 14,307,847 | 12,518,587 |
Effect of dilutive securities: | ||||
Options and restricted stock units | 0 | 12,397 | 0 | 0 |
Denominator for diluted loss per share weighted average shares | 16,795,356,000 | 12,517,493,000 | 14,307,847,000 | 12,518,587,000 |
Basic income (loss) per share | $ (0.15) | $ 0.06 | $ (0.10) | $ (0.08) |
Diluted income (loss) per share | $ (0.15) | $ 0.06 | $ (0.10) | $ (0.08) |
Income (Loss) per Share (Deta_2
Income (Loss) per Share (Details Narrative) - shares shares in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Restricted Stock Units [Member] | ||||
Antidilutive securities | 0 | 147,038 | ||
Stock Options [Member] | ||||
Antidilutive securities | 681,500 | 480,900 | 171,316 | 505,900 |
NonCash ShareBased Employee Com
NonCash ShareBased Employee Compensation (Details) | 9 Months Ended |
Sep. 30, 2021USD ($)$ / sharesshares | |
Non-Cash Share-Based Employee Compensation | |
Outstanding stock options | shares | 489,000 |
Vested stock options | shares | 185,800 |
Nonvested stock options | shares | 303,200 |
Expired stock options | shares | 10,000 |
Issued stock options | shares | 202,500 |
Outstanding stock options | shares | 681,500 |
Vested stock options | shares | 359,600 |
Nonvested stock options | shares | 321,900 |
Outstanding wgt. avg. exercise price | $ 3.96 |
Vested wgt. avg. exercise price | 4.15 |
Nonvested wgt. avg. exercise price | 3.84 |
Issued wgt. avg. exercise price | 3.08 |
Exercised wgt. avg. exercise price | 0 |
Forfeited wgt. avg. exercise price | 0 |
Expired wgt. avg. exercise price | 4.55 |
Outstanding wgt. avg. exercise price | 3.69 |
Vested wgt. avg. exercise price | 3.82 |
Nonvested wgt. avg. exercise price | $ 3.54 |
Outstanding contractual life, Beginning | 7 years 2 months 23 days |
Nonvested contractual life, Begining | 8 years 2 months 12 days |
Vested contractual life, Begining | 5 years 7 months 24 days |
Outstanding contractual life, Ending | 6 years 10 months 17 days |
Vested contractual life, Ending | 6 years |
Nonvested contractual life, Ending | 7 years 6 months 25 days |
Outstanding grant date fair value | $ 1.51 |
Vested grant date fair value | 1.55 |
Nonvested grant date fair value | 1.49 |
Issued grant date fair value | 1.16 |
Exercised grant date fair value | 0 |
Forfeited grant date fair value | 0 |
Expired grant date fair value | 1.06 |
Outstanding grant date fair value | 1.41 |
Vested grant date fair value | 1.44 |
Nonvested grant date fair value | $ 1.38 |
Outstanding aggregate intrinsic value | $ | $ 20,000,000 |
Vested aggregate intrinsic value | $ | 20,000,000 |
Nonvested aggregate intrinsic value | $ | 0 |
Issued aggregate intrinsic value | $ | 0 |
Forfeited aggregate intrinsic value | $ | 0 |
Exercised aggregate intrinsic value | $ | 0 |
Outstanding aggregate intrinsic value | $ | 15,000,000 |
Vested aggregate intrinsic value | $ | 15,000,000 |
Nonvested aggregate intrinsic value | $ | $ 0 |
NonCash ShareBased Employee C_2
NonCash ShareBased Employee Compensation (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | ||||||||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | Jun. 30, 2021 | Dec. 31, 2020 | Aug. 24, 2020 | Sep. 06, 2019 | Sep. 06, 2018 | Jun. 04, 2018 | |
Non-cash share-based employee compensation expense | $ 150,000 | $ 34,000 | $ 215,000 | $ 94,000 | ||||||
Restricted stock units outstanding | 171,316 | 147,038 | ||||||||
Restricted Stock Units [Member] | ||||||||||
Non-cash share-based employee compensation expense | $ 34,000 | $ 23,000 | $ 162,000 | $ 112,000 | ||||||
Fair value per award | $ 40,000 | $ 20,000 | $ 20 | |||||||
Aggregate grant date fair value | $ 280,000 | $ 140,000 | $ 140 | |||||||
Restricted Stock Units [Member] | Lewis Johnson [Member] | ||||||||||
Unvested stock units | 24,505 | |||||||||
Restricted Stock Units [Member] | Ryan Turner [Member] | ||||||||||
Unvested stock units | 10,389 | 4,050 |
Commitments and Contingencies (
Commitments and Contingencies (Details Narrative) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Commitments and Contingencies | ||||
Purchase commitments | $ 13,142 | $ 13,142 | ||
Sales to United States Government | $ 6,371 | $ 8,476 | $ 13,237 | $ 19,321 |
Percentage of sales | 50.50% | 66.40% | 39.40% | 57.50% |
Accounts receivable from US government | $ 5,197 | $ 3,261 | $ 5,197 | $ 3,261 |
Debt (Details)
Debt (Details) - USD ($) | Sep. 30, 2021 | Dec. 31, 2020 |
Notes payable-current portion | $ 264,000 | $ 82,000 |
Notes Payable to Banks Current [Member] | ||
Note payable-US. Bank | 84 | 82 |
Note payable-JP Morgan Chase Bank | 180 | 0 |
Notes payable-current portion | $ 264,000 | $ 82,000 |
Debt (Details 1)
Debt (Details 1) - Notes Payable to Banks, Long Term [Member] - USD ($) | Sep. 30, 2021 | Dec. 31, 2020 |
Note payable-US. Bank | $ 183 | $ 247 |
Note payable-JP Morgan Chase Bank | 490 | 0 |
Notes payable, Long term | $ 673,000 | $ 247,000 |
Debt (Details Narrative)
Debt (Details Narrative) - Credit Agreement $ in Thousands | Apr. 06, 2021USD ($)integer | Sep. 25, 2019USD ($)integer | Sep. 30, 2021USD ($) | Jan. 30, 2020USD ($) |
Line of credit commencing date | February 1, 2020 | |||
Line of credit, description | Borrowings under the Credit Agreement will bear interest at a rate per annum equal to one-month LIBOR or zero if the LIBOR is less than zero) plus a margin of 1.90% (1.973% as of September 30, 2021). | |||
Line of credit tangible net worth | $ 20,000 | |||
Line of credit maturity date | January 31, 2022 | |||
Line of credit | $ 5,000 | |||
Line of credit outstanding amount | $ 1,470 | |||
Line of credit net balance availability | $ 3,530 | |||
Master loan agreement amount | $ 743 | $ 425 | ||
Master loan agreement installments | integer | 48 | 60 | ||
Principal and interest payments | $ 16 | $ 8 | ||
Principal and interest payments, beginning date | May 8, 2021 | October 25, 2019 | ||
Principal and interest payments, maturity date | April 8, 2025 | September 25, 2024 | ||
Principal and interest payments, interest rate percentage | 3.00% | 5.11% |
Investment in Securities (Detai
Investment in Securities (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Percentage of net assets held | 100.00% | |||
Unrealized gains/loss on the investment | $ (310,000) | $ 797,000 | ||
FG Financial Group [Member] | ||||
Cash held | $ 63,000 | $ 63,000 | ||
Shares held by related party | 477,282 | |||
Fair value of shares | $ 2,324,000 | |||
Purchase of shares | 3,741,000 | |||
Unrealized gains/loss on the investment | $ 2,157 | $ 291,000 | $ 310,000 | $ 797,000 |
Aggregate shares owned by related party | 3,032,765 | |||
Percentage of common stock | 60.00% |
Income Taxes (Details Narrative
Income Taxes (Details Narrative) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Income Taxes | ||||
Income tax expense | $ 0 | $ 2 | $ 184 | $ 30 |
Net deferred tax assets | $ 4,116 | 4,116 | ||
Valuation allowance | $ 98 |
Leases (Details)
Leases (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Leases | ||||
Operating lease cost | $ 136,000 | $ 158,000 | $ 438,000 | $ 445,000 |
Short-term lease cost | 0 | 0 | 0 | 2,000 |
Variable lease cost | 33,000 | 33,000 | 98,000 | 96,000 |
Total lease cost | $ 169,000 | $ 191,000 | $ 536,000 | $ 543,000 |
Leases (Details 1)
Leases (Details 1) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Cash paid for amounts included in the measurement of lease liabilities: | ||||
Operating cash flows (fixed payments) | $ 143,000 | $ 141,000 | $ 495,000 | $ 384,000 |
Operating cash flows (liability reduction) | 104,000 | 102,000 | 375,000 | 267,000 |
ROU assets obtained in exchange for lease obligations: | ||||
Operating leases | $ 0 | $ 419,000 | $ 14,000 | $ 454,000 |
Leases (Details 2)
Leases (Details 2) | 9 Months Ended |
Sep. 30, 2021 | |
Leases | |
Weighted average remaining lease term (in years) | 5.44 |
Weighted average discount rate | 5.50% |
Leases (Details 3)
Leases (Details 3) $ in Thousands | Sep. 30, 2021USD ($) |
Leases | |
Remaining six months of 2021 | $ 144 |
2022 | 582 |
2023 | 595 |
2024 | 608 |
2025 | 618 |
Thereafter | 722 |
Total payments | 3,269 |
Less: imputed interest | (447) |
Total liability | $ 2,822 |
Leases (Details Narrative)
Leases (Details Narrative) | 1 Months Ended | 9 Months Ended | |
Mar. 31, 2021ft² | Feb. 29, 2020USD ($)ft² | Sep. 30, 2021USD ($)ft² | |
Leases | |||
Area of lease land | ft² | 8,100 | 6,857 | 54,000 |
Lease expiration date | December 31, 2021 | September 30, 2027 | |
Annual rental, maintenance and tax expenses on lease | $ | $ 196 | $ 491,000 | |
Increasing rate of percentage on annual rental, maintenance and tax expenses on lease | 3.00% | ||
Annual rental, maintenance and tax expenses description | Annual rental, maintenance and tax expenses for the facility will be approximately $196 for the first year, increasing by approximately 3% for each subsequent 12-month period. | ||
Lease term | 64 years |
Stockholders Equity (Details)
Stockholders Equity (Details) - USD ($) shares in Thousands | 3 Months Ended | 9 Months Ended | ||||||
Sep. 30, 2021 | Jun. 30, 2021 | Mar. 31, 2021 | Sep. 30, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Balance, amount | $ 23,628,000 | $ 23,628,000 | ||||||
Balance, amount | $ 33,244,000 | $ 22,649,000 | 33,244,000 | $ 22,649,000 | ||||
Common stock issued, net of issuance costs, amount | $ 11,559,000 | |||||||
Share-based compensation expense-restricted stock units | 162,000 | 112,000 | ||||||
Net income (loss): | (2,566,000) | 790,000 | (1,398,000) | (970,000) | ||||
Common Stock [Member] | ||||||||
Balance, amount | $ 10,941,000 | 8,392,000 | 8,377,000 | $ 8,366 | $ 8,357,000 | $ 8,357,000 | $ 8,377,000 | $ 8,357,000 |
Balance, amount | 10,941,000 | $ 8,392,000 | $ 8,366 | $ 8,357,000 | ||||
Common stock issued, net of issuance costs, amount | $ 2,549,000 | |||||||
Balance, shares | 18,236,121 | 13,986,871 | 13,962,366 | 13,943,820 | 13,929,381 | 13,929,381 | 13,962,366 | 13,929,381 |
Share-based compensation expense-stock options | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | ||
Share-based compensation expense-restricted stock units | 0 | 0 | 0 | 0 | 0 | 0 | ||
Common stock dividends ($0.02 per share) | 0 | 0 | 0 | 0 | 0 | |||
Net income (loss): | $ 0 | $ 0 | $ 0 | $ 0 | 0 | 0 | ||
Repurchase of common stock | $ 0 | 0 | ||||||
Common stock issued under restricted stock units, shares | 28,615 | 24,505 | 18,546 | 14,439 | ||||
Common stock issued under restricted stock units, amount | $ 17,000 | $ 15,000 | $ 11,000 | $ 9,000 | ||||
Common stock issued, net of issuance costs, shares | 4,249,250 | |||||||
Balance ending, shares | 18,264,736 | 13,962,366 | 13,929,381 | |||||
Balance ending, amount | 10,958 | 8,377 | 8,357 | |||||
Additional Paid-In Capital [Member] | ||||||||
Balance, amount | 35,534,000 | $ 26,466,000 | 26,346,000 | 26,235,000 | 26,146,000 | 26,095,000 | $ 26,346,000 | $ 26,095,000 |
Balance, amount | 35,534,000 | 26,466,000 | 26,235,000 | 26,146,000 | ||||
Common stock issued, net of issuance costs, amount | 9,010,000 | |||||||
Share-based compensation expense-stock options | 150,000 | 33,000 | 32,000 | 34,000 | 30,000 | 30,000 | ||
Share-based compensation expense-restricted stock units | 34,000 | 25,000 | 103,000 | 23,000 | 68,000 | 21,000 | ||
Common stock dividends ($0.02 per share) | 0 | 0 | 0 | 0 | 0 | |||
Net income (loss): | 0 | 0 | 0 | 0 | 0 | 0 | ||
Repurchase of common stock | 0 | 0 | ||||||
Common stock issued under restricted stock units, amount | (17,000) | (15,000) | (11,000) | (9,000) | ||||
Balance ending, amount | 35,071 | 26,281 | 26,095 | |||||
Retained Earnings (Accumulated Deficit) [Member] | ||||||||
Balance, amount | (4,776,000) | (6,614,000) | (5,693,000) | (7,147,000) | (6,601,000) | (6,043,000) | (5,693,000) | (6,043,000) |
Balance, amount | (4,776,000) | (6,614,000) | (7,147,000) | (6,601,000) | ||||
Common stock issued, net of issuance costs, amount | 0 | |||||||
Share-based compensation expense-stock options | 0 | 0 | 0 | 0 | 0 | 0 | ||
Share-based compensation expense-restricted stock units | 0 | 0 | 0 | 0 | 0 | 0 | ||
Common stock dividends ($0.02 per share) | (671,000) | (251,000) | (250,000) | (252,000) | (250,000) | |||
Net income (loss): | (2,566,000) | 1,838,000 | (670,000) | 790,000 | (294,000) | (1,466,000) | ||
Repurchase of common stock | 0 | 0 | ||||||
Common stock issued under restricted stock units, amount | 0 | 0 | 0 | 0 | ||||
Balance ending, amount | (8,013) | (6,607) | (4,885) | |||||
Change in inventory accounting method | 1,158,000 | |||||||
Treasury Stock [Member] | ||||||||
Balance, amount | (5,402,000) | (5,402,000) | (5,402,000) | (5,402,000) | (5,376,000) | (5,133,000) | (5,402,000) | (5,133,000) |
Balance, amount | (5,402,000) | (5,402,000) | (5,402,000) | (5,376,000) | ||||
Common stock issued, net of issuance costs, amount | 0 | |||||||
Share-based compensation expense-stock options | 0 | 0 | 0 | 0 | 0 | 0 | ||
Share-based compensation expense-restricted stock units | 0 | 0 | 0 | 0 | 0 | 0 | ||
Common stock dividends ($0.02 per share) | 0 | 0 | 0 | 0 | 0 | |||
Net income (loss): | 0 | 0 | 0 | 0 | 0 | 0 | ||
Repurchase of common stock | (26,000) | (243,000) | ||||||
Common stock issued under restricted stock units, amount | 0 | 0 | 0 | 0 | ||||
Balance ending, amount | (5,402) | (5,402) | ||||||
Total [Member] | ||||||||
Balance, amount | 36,297,000 | 22,842,000 | 23,628,000 | 22,052,000 | 22,526,000 | 23,276,000 | $ 23,628,000 | $ 23,276,000 |
Balance, amount | 36,297,000 | 22,842,000 | 22,052,000 | 22,526,000 | ||||
Share-based compensation expense-stock options | 150,000 | 33,000 | 32,000 | 34,000 | 30,000 | 30,000 | ||
Share-based compensation expense-restricted stock units | 34,000 | 25,000 | 103,000 | 23,000 | 68,000 | 21,000 | ||
Common stock dividends ($0.02 per share) | (671,000) | (251,000) | (250,000) | (252,000) | (250,000) | |||
Net income (loss): | (2,566,000) | $ 1,838,000 | (670,000) | 790,000 | (294,000) | (1,466,000) | ||
Repurchase of common stock | (26,000) | (243,000) | ||||||
Common stock issued under restricted stock units, amount | 0 | $ 0 | $ 0 | $ 0 | ||||
Balance ending, amount | $ 33,244 | |||||||
Change in inventory accounting method | $ 1,158,000 |